Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey J Pu

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
BMJ Case Reports|June 16, 2012
Gallbladder carcinosarcomaJeffrey J Pu, Weize Wu
Annals of Hematology|December 19, 2013
Successful discontinuation of eculizumab therapy in a patient with aHUSJeffrey J Pu, Abigail Sido
Clinical and Translational Science|June 29, 2011
Paroxysmal nocturnal hemoglobinuria from bench to bedsideJeffrey J Pu, Robert A Brodsky
Journal of Hematology & Oncology|May 12, 2023
Novel agents and evolving strategies in myelofibrotive neoplasm: an update from 2022 ASH annual conferenceAndrew Wang, James Liu, Jeffrey J Pu
Annals of Hematology|August 20, 2016
Primary myelofibrosis and its targeted therapyLindsey Shantzer, Kristin Berger, Jeffrey J Pu
Journal of Medical Cases|October 19, 2022
Immunocompetent Patient With Primary Bone Marrow Hodgkin LymphomaArmaan Dhaliwal, Vanessa F Eller, Jeffrey J Pu
Journal of Medical Cases|January 4, 2021
Resolution of Chronic Immune Thrombocytopenia Purpura after Autologous Hematopoietic Stem Cell Transplantation for Diffuse Large B-Cell LymphomaPrashanth A Kumar, Ali Wazir, Jeffrey J Pu
Annals of Hematology|November 7, 2015
Paraneoplastic cerebellar degeneration as an early sign of classical Hodgkin lymphomaJulie Chepovetsky, Amy S Duffield, Jeffrey J Pu
Frontiers in Oncology|June 18, 2024
Editorial: Checkpoint inhibition in hematologic malignanciesJeffrey J Pu, Joseph J Drabick, Susan E Prockop
Frontiers in Pediatrics|May 14, 2025
Editorial: Pediatric myeloid neoplasms: new insights into diagnosis, prognosis, and treatmentViviane Lamim Lovatel, Jeffrey J Pu, Teresa de Souza Fernandez
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
BMJ Case Reports|June 16, 2012
Gallbladder carcinosarcomaJeffrey J Pu, Weize Wu
Annals of Hematology|December 19, 2013
Successful discontinuation of eculizumab therapy in a patient with aHUSJeffrey J Pu, Abigail Sido
Clinical and Translational Science|June 29, 2011
Paroxysmal nocturnal hemoglobinuria from bench to bedsideJeffrey J Pu, Robert A Brodsky
Journal of Hematology & Oncology|May 12, 2023
Novel agents and evolving strategies in myelofibrotive neoplasm: an update from 2022 ASH annual conferenceAndrew Wang, James Liu, Jeffrey J Pu
Annals of Hematology|August 20, 2016
Primary myelofibrosis and its targeted therapyLindsey Shantzer, Kristin Berger, Jeffrey J Pu
Journal of Medical Cases|October 19, 2022
Immunocompetent Patient With Primary Bone Marrow Hodgkin LymphomaArmaan Dhaliwal, Vanessa F Eller, Jeffrey J Pu
Journal of Medical Cases|January 4, 2021
Resolution of Chronic Immune Thrombocytopenia Purpura after Autologous Hematopoietic Stem Cell Transplantation for Diffuse Large B-Cell LymphomaPrashanth A Kumar, Ali Wazir, Jeffrey J Pu
Annals of Hematology|November 7, 2015
Paraneoplastic cerebellar degeneration as an early sign of classical Hodgkin lymphomaJulie Chepovetsky, Amy S Duffield, Jeffrey J Pu
Frontiers in Oncology|June 18, 2024
Editorial: Checkpoint inhibition in hematologic malignanciesJeffrey J Pu, Joseph J Drabick, Susan E Prockop
Frontiers in Pediatrics|May 14, 2025
Editorial: Pediatric myeloid neoplasms: new insights into diagnosis, prognosis, and treatmentViviane Lamim Lovatel, Jeffrey J Pu, Teresa de Souza Fernandez
Pageof 5